+ All Categories
Home > Documents > Real World Evidence Technology Platform - Saama

Real World Evidence Technology Platform - Saama

Date post: 31-Oct-2021
Category:
Upload: others
View: 3 times
Download: 0 times
Share this document with a friend
2
ICONplc.com/RWI Real World Evidence Technology Platform Optimise Real World Data Use to Drive Effective Outcomes Real world evidence (RWE) continues to drive healthcare and research discussions and decisions. ICON works with biopharmaceutical and medical device companies to identify, generate, and communicate the clinical, safety and cost-effectiveness evidence that regulators, payers and providers demand. ICON’s holistic solution provides many distinct advantages including integrated domain expertise from across multiple disciplines covering epidemiology, data science, HEOR, study feasibility, market access and regulatory affairs. This expertise, combined with access to a diverse set of global RWD sources and a proven advanced analytics platform provider, Saama Technologies, creates a unique combination to more completely serve the expanding needs of biopharma’s Medical Affairs and RWE Centers of Excellence functions. ICON’s Strategic Approach to Actionable RWE Generation Our Commercialisation and Outcomes experts will collaborate with your subject matter experts to deliver a unique, intelligent RWE strategy for increased clinical research efficiency, and targeted plans that can enhance your value story and provide compelling evidence for stakeholder engagement. We call this approach Real World Intelligence . From interactive evidence planning workshops and strategy creation to implementation of innovative technology and RWD solutions, the ICON RWE team will ensure that you are on the clear path to commercial success, equipped with the right RWD assets to generate impactful evidence. RWE Planning Workshops and Strategy Creation Our interactive workshop approach brings together subject matter and functional experts to create a roadmap that aligns with your strategic objectives. You get a step-by-step plan to identify and execute a comprehensive RWE strategy customised for your specific asset. Identify Review product and portfolio objectives Assess Conduct a situational assessment Determine Recognise opportunities and challenges Define timing and resources for studies Plan Implement RWE generation and RWD acquisition plan Execute
Transcript
Page 1: Real World Evidence Technology Platform - Saama

ICONplc.com/RWI

Real World Evidence Technology PlatformOptimise Real World Data Use to Drive Effective Outcomes

Real world evidence (RWE) continues to drive healthcare and research discussions and decisions. ICON works with biopharmaceutical and medical device companies to identify, generate, and communicate the clinical, safety and cost-effectiveness evidence that regulators, payers and providers demand.

ICON’s holistic solution provides many distinct advantages including integrated domain expertise from across multiple disciplines covering epidemiology, data science, HEOR, study feasibility, market access and regulatory affairs. This expertise, combined with access to a diverse set of global RWD sources and a proven advanced analytics platform provider, Saama Technologies, creates a unique combination to more completely serve the expanding needs of biopharma’s Medical Affairs and RWE Centers of Excellence functions.

ICON’s Strategic Approach to Actionable RWE GenerationOur Commercialisation and Outcomes experts will collaborate with your subject matter experts to deliver a unique, intelligent RWE strategy for increased clinical research efficiency, and targeted plans that can enhance your value story and provide compelling evidence for stakeholder engagement. We call this approach Real World Intelligence™.

From interactive evidence planning workshops and strategy creation to implementation of innovative technology and RWD solutions, the ICON RWE team will ensure that you are on the clear path to commercial success, equipped with the right RWD assets to generate impactful evidence.

RWE Planning Workshops and Strategy CreationOur interactive workshop approach brings together subject matter and functional experts to create a roadmap that aligns with your strategic objectives. You get a step-by-step plan to identify and execute a comprehensive RWE strategy customised for your specific asset.

Identify

Review product and

portfolio objectives

Assess

Conduct a situational

assessment

Determine

Recognise opportunities

and challenges

Define timing and resources

for studies

Plan

Implement RWE generation and

RWD acquisition plan

Execute

Page 2: Real World Evidence Technology Platform - Saama

© 2019 ICON plc. All rights reserved. ICONplc.com/RWI

RWE Technology SolutionsThe evidence generated from collecting, standardising and analysing RWD from primary and secondary sources can be used across an array of late phase research applications. With a full understanding of the novel RWD sources and innovative technologies to gather, process and analyse them, a more robust approach exists for creating RWE results.

Innovative Approach to RWE Technology

Partnerships Greater Use of Secondary RWD

EHR Research Platforms

Patient Centric Technologies

– RWD Sources – Technology Enablement – Future Investments

– Innovative Study Designs – Patient Recruitment

– Hybrid Studies – Backbone for Data

Collection – Pragmatic Trials

– ePRO, Retention and Recruitment

– Virtual Studies – Wearables

RWE Technology PlatformICON provides a configurable technology platform, leveraging Saama’s Life Science Analytics Cloud, that is a fit-for-purpose solution to support and enhance your observational research needs, to gather disparate RWD assets into a common data model, provide analytics to support multiple audiences across the product lifecycle, and establish a central repository and analytic platform for all of your RWD assets. Key capabilities provided by the platform include:

Powered by

Life Science Analytics Cloud

Data Parsing & Integration

Data Quality

Common Data Model

Machine Learning

Analysis

Governance, Compliance & Monitoring

Patient Inputs

ProviderInputs

Trial Management

Inputs

OtherInputs

Accelerate Patient Population Identi�cation/Recruitment

Better Business & Patient Outcomes

Shorten Trial Design, Site/PI Selection Time & Costs

Patient Data Standardisation & Analytics

Predictive Operational KPIs

Risk Identi�cation

Modern Patient Registries

Value-based Reimbursements

KOL Engagement

Patient Journey

Treatment Pathways

Payer Insights

Market Analysis

AI/ML based Literature Review

Insights

Protocol Design (I/E Recommender)

Predictive Protocol & Trial Feasibility

Predictive Site, PI, Patient Identi�cation and Enrolment Forecasting

Study Start-up Automation

Planning

Start Up

Conduct

RWE

Patient Matching

Trial Feasibility RWD

Study Management

Sample Ecosystem

Let our industry experts work for youContact us today at ICONplc.com/contact

For access to our webinars and whitepapers, visit ICONplc.com/RWI


Recommended